Skip to main content Skip to footer
Algernon Pharmaceuticals Inc.
  • Home
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Medical & Scientific Advisors
  • Alzheimer’s
    • Overview
    • AD Clinics
    • Markets
    • Resources
  • Pipeline
    • Overview
    • NP-251 (Repirinast)
    • AP-188 (DMT)
  • Companies
    • Algernon NeuroScience
  • News & Media
    • News Releases
    • IR Calendar
    • Presentations
    • Videos/Articles
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEDAR
    • Governance
  • Contact

News Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • News Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Annual General Meeting
    • Analysts
  • Stock Data
    • CSE:AGN
    • OTCQB:AGNPF
    • XFRA:AGW0
  • SEDAR
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • News Releases
  • IR Calendar
  • Email Alerts
Mar 13, 2020 8:30am EDT

Algernon Announces Filing of U.S. FDA Pre-IND Meeting Request for Ifenprodil Coronavirus Trial, Expanded Access, and Emergency Use

Mar 11, 2020 3:17pm EDT

Algernon Announces Exercise of Warrants and Broker Warrants

Mar 10, 2020 8:46am EDT

Algernon Announces Coronavirus Update Featured on BioPub Hosted by Dr. KSS MD PhD

Mar 09, 2020 8:45am EDT

Algernon Scales up Manufacturing of NP-120 (Ifenprodil) to Prepare for Coronavirus and Acute Lung Injury US Clinical Trials

Mar 06, 2020 2:34pm EST

Algernon Announces Availability of its NP-120 Ifenprodil Drug for Compassionate Use for Coronavirus

Mar 06, 2020 6:09am EST

Algernon Explores the Use of NP-120 (Ifenprodil) as a Novel Treatment for Coronavirus

Feb 26, 2020 6:00am EST

Algernon Pharmaceuticals to be Featured on BioPub Webcast Hosted by Dr. KSS MD PhD

Feb 21, 2020 6:00am EST

Algernon Pharmaceuticals Announces Increase and Closing of CDN$1.55M Private Placement

Feb 13, 2020 9:00am EST

Algernon Pharmaceuticals Announces Private Placement

Feb 07, 2020 6:00am EST

Algernon Pharmaceuticals Appoints Professor of Respiratory Medicine Dr. Jacky Smith to Its Medical and Scientific Advisory Board

  • Previous Pagearrow_back
  • Page 1…
  • …
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Next Pagearrow_forward
rss_feed News RSS
  • Visit us on Facebook

    Facebook

  • Visit us on Twitter

    Twitter

  • Visit us on LinkedIn

    LinkedIn

  • Email Alerts
  • Email Alerts
  • Contacts
  • RSS News Feed
©2025 Algernon Pharmaceuticals Inc. All Rights Reserved.
Privacy Policy Sitemap